scispace - formally typeset
S

Sancy A. Leachman

Researcher at Oregon Health & Science University

Publications -  245
Citations -  9037

Sancy A. Leachman is an academic researcher from Oregon Health & Science University. The author has contributed to research in topics: Melanoma & Cancer. The author has an hindex of 50, co-authored 229 publications receiving 7890 citations. Previous affiliations of Sancy A. Leachman include Mayo Clinic & Yale University.

Papers
More filters
Journal ArticleDOI

Revised nomenclature and classification of inherited ichthyoses: Results of the First Ichthyosis Consensus Conference in Sorèze 2009

TL;DR: An international consensus is achieved for the classification of inherited ichthyosis that should be useful for all clinicians and can serve as reference point for future research.
Journal ArticleDOI

High-risk Melanoma Susceptibility Genes and Pancreatic Cancer, Neural System Tumors, and Uveal Melanoma across GenoMEL

Alisa M. Goldstein, +99 more
- 15 Oct 2006 - 
TL;DR: This GenoMEL study provides the most extensive characterization of mutations in high-risk melanoma susceptibility genes in families with three or more melanoma patients yet available and there was little evidence for an association between CDKN2A mutations and NST, but there was a marginally significant association between NST and ARF.
Journal ArticleDOI

Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma‐prone families from three continents

TL;DR: The variation in CDKN2A mutations for the four features across continents is consistent with the lower melanoma incidence rates in Europe and higher rates of sporadic melanoma in Australia, which reflects the divergent spectrum of mutations in families from Australia versus those from North America and Europe.
Journal ArticleDOI

Melanocytes as Instigators and Victims of Oxidative Stress

TL;DR: The current knowledge about melanin and the redox state of melanocytes, how paracrine factors help counteract oxidative stress, the role of oxidative stress in melanoma initiation and progression and in melanocyte death in vitiligo is reviewed, and how this knowledge can be harnessed for melanoma and Vitiligo treatment is reviewed.